Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ephedrine Dosage for Cerebral Blood Flow in Neonates
NCT06257316Phase 4Not yet recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Feb 2024
- Primary completion
- Feb 2027
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of ephedrine in Neonatal hypotension, sponsored by Seoul National University Hospital. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
ephedrine
03
Conditions
Neonatal hypotension
Beyond the preview
Go deeper on NCT06257316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06257316.